Related references
Note: Only part of the references are listed.Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?
Andrea J. Zimmer et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients receiving chemotherapy
Shaozhen Chen et al.
JOURNAL OF CANCER (2021)
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa
C. Gudiol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis
Wei-min Zhu et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2020)
Infections Due to Carbapenem-Resistant Bacteria in Patients With Hematologic Malignancies
Rym Lalaoui et al.
FRONTIERS IN MICROBIOLOGY (2020)
Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences
Marianna Criscuolo et al.
ANTIBIOTICS-BASEL (2020)
Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients
Morgan Hakki et al.
CLINICAL INFECTIOUS DISEASES (2019)
Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies
Duygu Mert et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2019)
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey
Enrico Maria Trecarichi et al.
PLOS ONE (2019)
Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study
Winfried Kern et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria
C. Cattaneo et al.
ANNALS OF HEMATOLOGY (2018)
Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections
Yishu Tang et al.
INFECTION (2018)
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines
Malgorzata Mikulska et al.
JOURNAL OF INFECTION (2018)
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group
Diana Averbuch et al.
CLINICAL INFECTIOUS DISEASES (2017)
Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome
Polydoros Tofas et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
Enrico Maria Trecarichi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey
E. M. Trecarichi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antibiotic Pressure Is a Major Risk Factor for Rectal Colonization by Multidrug-Resistant Pseudomonas aeruginosa in Critically Ill Patients
Silvia Gomez-Zorrilla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study
M. Giannella et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact
Enrico M. Trecarichi et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
Carbapenemase-producing Klebsiella pneumoniae and Hematologic Malignancies
Livio Pagano et al.
EMERGING INFECTIOUS DISEASES (2014)
Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections
Enrico Maria Trecarichi et al.
FUTURE MICROBIOLOGY (2012)
Identifying Patients Harboring Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections
P. Rattanaumpawan et al.
JOURNAL OF HOSPITAL INFECTION (2010)
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
G Bucaneve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported
MK Bolon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Share Paper
